SCHEMBL22012729

SCHEMBL22012729

CC(C)COC(=O)c1cccc(S(N)(=O)=O)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
TSHR P16473 1/20 0.46
CYP1A2 P05177 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
CNR2 P34972 1/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 3/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
NPY1R P25929 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962368 0.79 MAPT (0.47) ALDH1A1CYP1A2CA2CA12CA1
SCHEMBL31475656 0.79 MAPT (0.47) ALDH1A1CYP1A2CA2CA12CA1
SCHEMBL19623129 0.74 ALDH1A1 (0.49) ALDH1A1TSHRCYP1A2L3MBTL1LMNA
SCHEMBL3465738 0.72 PIM1 (0.47) ALDH1A1TSHRCNR2CA2CA12
SCHEMBL27101915 0.70 ALDH1A1 (0.59) ALDH1A1TSHRL3MBTL1LMNANPC1
SCHEMBL20188582 0.69 ALDH1A1 (0.53) ALDH1A1TSHRCYP1A2L3MBTL1LMNA
SCHEMBL161503 0.69 ALDH1A1 (0.45) ALDH1A1TSHRCYP1A2L3MBTL1LMNA
SCHEMBL30817753 0.69 ALDH1A1 (0.53) ALDH1A1TSHRCYP1A2L3MBTL1LMNA
SCHEMBL14767681 0.69 CA12 (0.63) ALDH1A1TSHRCA2CA12CA1
SCHEMBL164480 0.68 ALDH1A1 (0.47) ALDH1A1TSHRCYP1A2L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed